Literature DB >> 946747

Effect of long term use of oral contraceptives on glucose tolerance.

B R Muck.   

Abstract

The effect of long term use of oral contraceptives on glucose tolerance was studied in 133 women. Oral contraceptives were taken for a period between 3 and 12 years. 25 women without any hormone treatment served as a control group. The intravenous glucose tolerance test (IVGTT) has indicated no pathological decrease of glucose tolerance, measured by k. The glucose tolerance test was performed on all subjects (0.33 Gm. of glucose per kg bodyweight). In one subject we diagnosticated a clinical diabetes. Two patients had a subclinical diabetes. After 10 years of treatment a significant decline was noted in k, also in women with family history of diabetes or a past obstetrics history. Several doubtfully pathological k-values were recorded in women more than 40 years of age. No significant relation could be established between parity and the developement of an abnormal glucose metabolism, while taking the drugs. The effect upon glucose tolerance is not related to the type of oral contraceptive. The evidence is not sufficient to warrant the elimination of oral contraceptives. In is suggested that at least in diabetes suspects, repeated controls of glucose tolerance be carried out during long term cyclic use of oral contraceptives.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 946747     DOI: 10.1007/bf00667746

Source DB:  PubMed          Journal:  Arch Gynakol        ISSN: 0003-9128


  23 in total

1.  GLUCOSE TOLERANCE IN WOMEN RECEIVING AN OVULATORY SUPPRESSANT.

Authors:  H GERSHBERG; Z JAVIER; M HULSE
Journal:  Diabetes       Date:  1964 Jul-Aug       Impact factor: 9.461

2.  The effect of estrogen on intravenous glucose tolerance in woman.

Authors:  J A Goldman; J L Ovadia
Journal:  Am J Obstet Gynecol       Date:  1969-01-15       Impact factor: 8.661

3.  [On the problem of endocrine side effects of ovulation inhibitors. Effect on glucose tolerance, nonesterified fatty acids, insulin and cortisol levels as well as protein-bound iodine and triiodothyronine in the serum].

Authors:  P Bottermann; P Dieterle; W Hochheuser; K Horn; K Kopetz; K Schleypen; K Schwarz; P C Scriba
Journal:  Munch Med Wochenschr       Date:  1967-03-31

4.  Insulin and glucose studies after one year of treatment with a sequential-type oral contraceptive.

Authors:  W N Spellacy; W C Buhi; R P Bendel
Journal:  Obstet Gynecol       Date:  1969-06       Impact factor: 7.661

5.  One-hour glucose tolerance in relation to the use of contraceptive drugs.

Authors:  N Phillips; T Duffy
Journal:  Am J Obstet Gynecol       Date:  1973-05-01       Impact factor: 8.661

6.  Continuous norethindrone, 0.35 mg., as an oral contraceptive agent.

Authors:  J A Board
Journal:  Am J Obstet Gynecol       Date:  1971-02-15       Impact factor: 8.661

7.  The effect of pseudopregnancy by ovulatory suppressants on the glucose tolerance in women.

Authors:  J A Goldman; B Eckerling; J Ovadia
Journal:  Fertil Steril       Date:  1969 May-Jun       Impact factor: 7.329

8.  Effect of an ovulatory suppressant on glucose tolernce and insulin secretion.

Authors:  F X Pi-Sunyer; S Oster
Journal:  Obstet Gynecol       Date:  1968-04       Impact factor: 7.661

9.  Blood glucose levels and glucose tolerance in women with subclinical diabetes receiving an oral contraceptive.

Authors:  J A Goldman; B Eckerling
Journal:  Am J Obstet Gynecol       Date:  1970-05-15       Impact factor: 8.661

10.  Plasma insulin and blood glucose levels in patients taking oral contraceptives. A preliminary report of a prospective study.

Authors:  W N Spellacy; K L Carlson
Journal:  Am J Obstet Gynecol       Date:  1966-06-15       Impact factor: 8.661

View more
  2 in total

1.  Oral contraceptives and diabetes mellitus.

Authors:  S J Wingrave; C R Kay; M P Vessey
Journal:  Br Med J       Date:  1979-01-06

2.  [Effect of oral contraceptives on plasma insulin and blood glucose levels after long term use (author's transl)].

Authors:  B R Muck; G Hommel
Journal:  Arch Gynakol       Date:  1976
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.